Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
General Outpatient Psychiatry
•
Neuromodulation
•
Ketamine
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
Related Questions
How do you determine the treatment course of esketamine or IV ketamine when used for treatment-resistant major depressive disorder?
What is your experience with transcutaneous vagal nerve stimulation for the treatment of anxiety disorders and major depressive disorder?
How would you manage acute panic symptoms in a patient with alcohol use disorder in sustained remission who is starting an SSRI for panic disorder?
How do you approach patient requests for medical time away from work or other accommodations (such as disability paperwork) when the patients have mild-moderate symptoms being managed in the outpatient setting?
How do you approach anxiety management for patients who have been on long-term (years or more) daily benzodiazepines?
What strategies have you found helpful for balancing telehealth and in-person appointments to reduce bottlenecks?
How do you treat patients with comorbid Bipolar Disorder and ADHD?
How do you manage fatty liver disease in patients on olanzapine who are reluctant to change meds?
How do you approach the use of antipsychotics, such as Seroquel/Zyprexa, for insomnia in patients unresponsive to standard treatments?
How do you treat postpartum obsessive-compulsive disorder?
